Search clinical trials for: Anakinra

Total 168 results

University of Athens

Completed

Effects of Interleukin-1 Inhibition on Vascular and Left Ventricular Function in Rheumatoid Arthritis Patients With Coronary Artery Disease

Coronary Artery Disease | Inflammation | Rheumatoid Arthritis

Greece
Weill Medical College of Cornell University
Swedish Orphan Biovitrum

Withdrawn

Anakinra, COVID-19, Cytokine Storm (SOBI)

Covid19 | Mechanical Ventilation Complication | Cytokine Storm

United States
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI)

Withdrawn

Early Phase Administration of Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation (EarlyAna)

Asthma
Virginia Commonwealth University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Interleukin-1 Blockade in Recently Decompensated Heart Failure (RED-HART)

Heart Failure

United States
Virginia Commonwealth University
American Heart Association

Completed

Interleukin (IL)-1 Blockade in Acute Heart Failure (Anakinra ADHF)

Heart Failure

United States
Amgen

Terminated

The SPECTRA Study

Rheumatoid Arthritis
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI)

Withdrawn

Late Phase Administration Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation (LateAna)

Asthma
National Institute of Neurological Disorders and...

Completed

Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis

Multiple Sclerosis

United States
National Institute of Arthritis and Musculoskeletal...

Completed

Anakinra for Behcet s Disease

Immune System Diseases | Autoimmune Connective Tissue Disorder

United States
National Institute of Allergy and Infectious Diseases...

Terminated

A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis

Eczema | Atopic Dermatitis | Allergic Disease | Anakinra | Kineret

United States
National Cancer Institute (NCI)

Completed

Anakinra in Treating Patients With Metastatic Cancer Expressing the Interleukin-1 Gene

Unspecified Adult Solid Tumor, Protocol Specific

United States
Karolinska Institutet

Completed

Anakinra in Myositis

Dermatomyositis | Polymyositis | Inclusion Body Myositis

Sweden
University Hospital, Basel, Switzerland

Recruiting

Hyperinsulinemia in Prediabetes Mediated by Interleukin-1β (Hyper-PreDIL)

PreDiabetes | Hyperinsulinemia

Switzerland
Oxford University Clinical Research Unit, Vietnam
Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam

Recruiting

Anakinra in Dengue With Hyperinflammation ( AnaDen )

Cytokine Storm | Dengue | Severe Dengue | Macrophage Activation Syndrome | Anakinra | Dengue With Warning Signs | Anti-inflammatory Agents | Hyperinflammatory Syndrome | Immuno-modulation

Vietnam
Virginia Commonwealth University
American Heart Association; National Center for Advancing Translational Sciences...

Recruiting

Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis (MAGiC-ART)

Cardiac Sarcoidosis

United States
Virginia Commonwealth University

Recruiting

Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2 (REDHART2)

Inflammation | Heart Failure, Systolic

United States
Rennes University Hospital

Terminated

Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study (THERA)

Refractory Hemochromatosis Rheumatism

France
National Institute of Arthritis and Musculoskeletal...

Terminated

Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease

Nervous System Malformations | Urticaria | Papilledema | Arthropathy, Neurogenic

United States
Centre Hospitalier Intercommunal de Toulon La Seyne...
Assistance Publique Hopitaux De Marseille; Hôpital d'instruction des armées...

Terminated

Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation (JAKINCOV)

Covid-19

France
Virginia Commonwealth University

Terminated

Treatment of Acute Pericarditis With Anakinra

Acute Pericarditis

United States
University of Utah

Completed

Interleukin-1 Receptor Antagonist for the Treatment of Heart Failure in Patients With Left Ventricular Assist Devices

Heart Failure

United States
Swedish Orphan Biovitrum

Completed

Long-term Safety Study of Kineret® in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)

Still Disease, Juvenile Onset

Italy
Assistance Publique - Hôpitaux de Paris
Swedish Orphan Biovitrum

Completed

Anakinra and Kawasaki Disease (KAWAKINRA)

Children | Kawasaki Disease

France
Andrea Vambutas
National Institute on Deafness and Other Communication Disorders (NIDCD)

Completed

A Clinical Trial of Anakinra for Steroid-Resistant Autoimmune Inner Ear Disease

Sensorineural Hearing Loss | Autoimmune Inner Ear Disease

United States
Andrea Vambutas

Terminated

Study of the Effects of Anakinra in Corticosteroid-resistant Subjects With Sudden Sensorineural Hearing Loss (SSNHL)

Hearing Loss, Sudden

United States
Massimo Imazio

Completed

AnakInRa for Treatment of Recurrent Idiopathic Pericarditis (AIRTRIP) (AIR TRIP)

Idiopathic Recurrent Pericarditis

Italy
Michelle Hernandez, MD
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Effect of Interleukin-1 Receptor Antagonist on Inhalation of 20,000 EU Clinical Ctr Reference Endotoxin in Normal Volunteers (Kintox)

Healthy Control Subjects

United States
Amgen

Completed

Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis

Rheumatoid Arthritis
Northwell Health
Swedish Orphan Biovitrum

Recruiting

Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease

Meniere's Disease | Autoimmune Inner Ear Disease

United States
Virginia Commonwealth University
National Institute on Aging (NIA); University of Virginia

Recruiting

Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart Failure (Virginia-ART4)

Heart Failure

United States
Radboud University Medical Center
Dutch Heart Foundation

Recruiting

Studying Anakinra to Reduce Secondary Brain Damage After Spontaneous Haemorrhagic Stroke (ACTION)

Intracerebral Hemorrhage

Netherlands
Virginia Commonwealth University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Interleukin-1 Blockade in HF With Preserved EF (D-HART2)

Heart Failure With Normal Ejection Fraction

United States
University of California, San Francisco

Completed

Anakinra as a Treatment for Hydradenitis Suppurativa

Hidradenitis Suppurativa

United States
Swedish Orphan Biovitrum
CMIC Co, Ltd. Japan

Recruiting

A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)

Still's Disease, Adult-Onset | Still's Disease, Juvenile Onset

Japan
University of Alberta

Completed

Management of Persistent Epistaxis Using Floseal Hemostatic Matrix

Epistaxis

Canada
Virginia Commonwealth University

Withdrawn

Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney Disease (E-HART)

Chronic Kidney Diseases | Heart Failure, Systolic | Renal Disease, End Stage
Duke University

Completed

Study to Prevent Cartilage Damage Following Acute Knee Injury.

Knee Injury

United States
Amgen

Completed

Anakinra (Kineret®) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA)

Rheumatoid Arthritis
Assistance Publique Hopitaux De Marseille

Unknown

A Trial Using ANAKINRA, TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease (INFLAMMACOV)

Covid19

France
Azienda Ospedaliero, Universitaria Ospedali Riuniti

Recruiting

Therapy Management in Patients Treated With Anakinra Due to Recurrent Pericarditis

Recurrent Pericarditis

Italy
Virginia Commonwealth University

Recruiting

The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART) (AID-HEART)

Heart Failure

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy

B-Cell Lymphoma | B-cell Non Hodgkin Lymphoma | B Cell ALL

United States
Assistance Publique - Hôpitaux de Paris

Completed

CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection (CORIMUNO-ANA)

Corona Virus Infection

France
National Institute of Neurological Disorders and...
Johns Hopkins University

Terminated

Anakinra, A Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 Infection

HIV Infections | Neurologic Disorders

United States
Virginia Commonwealth University
National Institutes of Health (NIH); National Center for Research Resources...

Completed

Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Heart Failure

Heart Failure

United States
Reza Dana, MD

Completed

Topical IL-1-Ra for Treatment of Posterior Blepharitis

Posterior Blepharitis
Centre Georges Francois Leclerc

Completed

Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Metastatic Colorectal Cancer (IRAFU)

Metastatic Colorectal Cancer

France
Hellenic Institute for the Study of Sepsis

Completed

suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE) (SAVE)

Virus Diseases | COVID-19 | Corona Virus Infection | Lower Respiratory Tract Infection Viral

Greece
Janssen Research & Development, LLC

Completed

A Study of JNJ-77474462 in Healthy Participants

Healthy

Australia
Handok Inc.

Completed

A Dose-Block Randomized, Placebo Controlled (Double-blind), Active Controlled(Open-label), Dose-escalation Study

Healthy Volunteers

Korea, Republic of

Search clinical trials for: Anakinra

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations